A significant discovery in cancer study is arising with the use of mini-antibodies to re-engage damaged p53. This vital tumor inhibitor protein is frequently disabled in various kinds of malignancies, resulting https://linkingbookmark.com/story21837286/vhh-fragments-revive-p53-new-new-pathway-for-malignant-management